New Hope for patients with major depressive disorder

A new, non-invasive
treatment option

NeuroStar TMS Therapy is a non-invasive, 40-minute outpatient procedure that does not require sedation or anesthesia. Clinical trials have studied its efficacy and safety in treating depressed patient who have had an inadequate response to previous therapies. Read more.

To view NeuroStar TMS Therapy clinical data presentations,
click here.

Despite advances in treatment, major depression remains a serious problem.

Major depression is a common and serious medical illness affecting more than 13 million Americans, or approximately 6.6 percent of the population in a given year. Read more.

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

This study was recently published in the December 2007 issue of Biological Psychiatry. To read the article abstract or obtain a full text copy, click here. To view the press release written and issued by the peer-reviewed psychiatry journal, Biological Psychiatry, click here.

Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction Treatment

This article was recently published in the February 2008 issue of The Journal of Clinical Psychiatry. To read the article abstract or obtain a full text copy, click here. To view the press release, click here.